Friday, November 30, 2012 Thursday, November 29, 2012- It's Official -- Abbott Labs Will Change Foreverat Motley Fool (Thu, Nov 29)
- Ex-Orioles Player DeCinces Charged With Insider Tradingat Bloomberg (Thu, Nov 29)
- Big Changes Up Ahead for Abbott Investorsat Motley Fool (Thu, Nov 29)
- Abbott Labs' new Worcester facility to become part of AbbVie spinoffat bizjournals.com (Thu, Nov 29)
- Buy Johnson & Johnson For Rock Solid Dividends - No Capital Appreciation Expectedat Seeking Alpha (Thu, Nov 29)
- NVS Discusses Data Readout PlansZacks (Thu, Nov 29)
- Abbott Labs Gets a Makeoverat Motley Fool (Thu, Nov 29)
- Hi-Tech Pharmacal Set To Drop By 60% On Earnings And Fraud Investigationsat Seeking Alpha (Thu, Nov 29)
- Gilead Reports Positive HCV DataZacks (Thu, Nov 29)
- Abbott directors approve AbbVie splitAP (Thu, Nov 29)
- Stocks to Watch: TIF, LTD, NKE & Moreat CNBC (Thu, Nov 29)
- Manufacturing activity slows amid fiscal cliff concernsat bizjournals.com (Thu, Nov 29)
- Will GE Find Money in This New Focus on Service?at Wall St. Cheat Sheet (Thu, Nov 29)
Wednesday, November 28, 2012- APNewsBreak: DeCinces indicted for insider tradingAP (Wed, Nov 28)
- Idenix Gets a Big Buy Recat Motley Fool (Wed, Nov 28)
- Billionaire Ken Fisher Thinks Pfizer is Right for Youat Motley Fool (Wed, Nov 28)
- ABBOTT LABORATORIES Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Nov 28)
- First to Phase 3! Whoopee?at Motley Fool (Wed, Nov 28)
- Will Pfizer Finally Fail?at Motley Fool (Wed, Nov 28)
- Is Gilead Sciences Still A Good Buy?at Seeking Alpha (Wed, Nov 28)
- Abbott's Humira's Label ExpandedZacks (Wed, Nov 28)
- Another Emerging Markets Move for Big Pharmaat Motley Fool (Wed, Nov 28)
Add ABT News to My Yahoo!   | |
|
1.35%